Treatment of cats with feline infectious peritonitis

Veterinary Immunology and Immunopathology

Volumn 123, Issue 1-2, 2008, Pages 172-175

  Hartmann, Katrin ^a   Ritz, Susanne ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cat; Feline infectious peritonitis; Review; Treatment

Indexed keywords

AMPICILLIN; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; INTERFERON; MELPHALAN; OZAGREL; PREDNISOLONE; PREDNISONE; RIBAVIRIN; STREPTOKINASE; TYLOSIN;

CAT; CAT DISEASE; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG SCREENING; HISTOPATHOLOGY; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; SHORT SURVEY; TREATMENT DURATION; VETERINARY MEDICINE; VITAMIN SUPPLEMENTATION;

ANIMALS; CATS; CORONAVIRUS, FELINE; FELINE INFECTIOUS PERITONITIS; IMMUNOSUPPRESSIVE AGENTS;

ANIMALIA; FELIDAE; FELINE CORONAVIRUS;

EID: 43049164415     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.01.026     Document Type: Short Survey

References (25)

1. Baba T., Yamashita N., Kodama H., Mukamoto M., Asada M., Nakamoto K., Nose Y., and McGruder E.D. Effect of tylosin tartrate (tylan soluble) on cellular immune responses in chickens. Poult. Sci. 77 (1998) 1306-1311
2. Barlough J.E., and Scott F.W. Effectiveness of three antiviral agents against FIP virus in vitro. Vet. Rec. 126 (1990) 556-558
3. Bilkei G. Beitrag zur Therapie der FIP. Tierarztl. Umsch. 43 (1988) 192-196
4. Bölcskei A., and Bilkei G. Langzeitstudie über FIP-verdächtige Katzen. Tierärztl. Umschau. 50 (1995) 721-728
5. Chang W.-L., Su W.-L., Pang V.F., and Pan M.-J. Treatment of Two cases of feline infectious peritonitis 35 (1995), Memories College Agriculture National Taiwan University pp. 480-487
6. Colgrove D.J., and Parker A.J. Feline infectious peritonitis. J. Small Anim. Pract. 12 (1971) 225-232
7. Disque D.F., Case M.T., and Youngren J.A. Feline infectious peritonitis. J. Am. Vet. Med. Assoc. 152 (1968) 372-375
8. Ford R.B. Biological response modifiers in the management of viral infections. Vet. Clin. North Am. Small Anim. Pract. 16 (1986) 1191-1204
9. Fraschini F., Scaglione F., Ferrara F., Marelli O., Braga P.C., and Teodori F. Evaluation of the immunostimulating activity of erythromycin in man. Chemother. 32 (1986) 286-290
10. Hartmann K. Feline infectious peritonitis: new aspects of diagnosis and treatment. Proceedings of the 24th Annual ACVIM (American College of Veterinary Internal Medicine) Forum. Louisville, USA (2006) 591-593
11. Hiraku S., Taniguchi K., Wakitani K., Omawari N., Kira H., Miyamoto T., Okegawa T., Kawasaki A., and Ujiie A. Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046). Jpn. J. Pharmacol. 41 (1986) 393-401
12. Ishida T., Shibanai A., Tanaka S., Uchida K., and Mochizuki M. Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis. J. Feline Med. Surg. 6 (2004) 107-109
13. Katahira J., Haruki K., Shibata Y., Kikuchi K., Hasegawa H., Totsuka K., and Shimizu K. Studies on the effects of erythromycin on interleukin-1 and tumor necrosis factor production. Chemother. 39 (1991) 320-327 (in Japanese)
14. Katahira J., Kikuchi K., Shibata Y., Hasegawa H., Totsuka K., and Shimizu K. Kinetic studies on the effects of macrolides on cytokine reduction. Chemother. 39 (1991) 678-686 (in Japanese)
15. Madewell B.R., Crow S.E., and Nickerson T.R. Infectious peritonitis in a cat that subsequently developed a myeloproliferative disorder. J. Am. Vet. Med. Assoc. 172 (1978) 169-172
16. Mochizuki M., Nakatani H., and Yoshida M. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Vet. Microbiol. 39 (1994) 145-152
17. Ras G.J., and Anderson R. An in-vitro study of oral therapeutic doses of co-trimoxazole and erythromycin stearate on abnormal polymorphonuclear leucocyte migration. J. Antimicrob. Chemother. 17 (1986) 185-193
18. Ritz S.J., Egberink H., and Hartmann K. Influence of feline interferon-omega on the survival time and quality of life of cats with feline infectious peritonitis. J. Vet. Intern. Med. 21 (2007) 1193-1197
19. Robison R.L. Feline Fibrinous Peritontitis (1968), W.B. Saunders Company, Philadelphia pp. 583-584
20. Robison R.L., Holzworth J., and Gilmore C.E. Naturally occurring feline infectious peritonitis: signs and clinical diagnosis. J. Am. Vet. Med. Assoc. 158 Suppl. 2 (1971) 981-986
21. Watari T., Kaneshima T., Tsujimoto H., Ono K., and Hasegawa A. Effect of thromboxane synthetase inhibitor on feline infectious peritonitis in cats. J. Vet. Med. Sci. 60 (1998) 657-659
22. Weiss R.C., and Oostrom-Ram T. Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro. Vet. Microbiol. 20 (1989) 255-265
23. Weiss R.C., Cox N.R., and Oostrom-Ram T. Effect of interferon or Propionibacterium acnes on the course of experimentally induced feline infectious peritonitis in specific-pathogen-free and random-source cats. Am. J. Vet. Res. 51 (1990) 726-733
24. Weiss R.C., Cox N.R., and Boudreaux M.K. Toxicologic effects of ribavirin in cats. J. Vet. Pharmacol. Ther. 16 (1993) 301-316
25. Weiss R.C., Cox N.R., and Martinez M.L. Evaluation of free or liposome-encapsulated ribavirin for antiviral therapy of experimentally induced feline infectious peritonitis. Res. Vet. Sci. 55 (1993) 162-172